Bristol Myers Squibb Canada (BMS) is currently experiencing a constrained supply of ORENCIA SC (abatacept for subcutaneous injection 125 mg/mL)

Please see the official press release: Orencia SC Payer Letter_03.19.2024_FINAL_ENGLISH (1)